Biotechnology Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More – ATAI Life Sciences (NASDAQ:ATAI), Algernon Pharmaceuticals (OTC:AGNPF) Read more
Cannabis Who’s Who In Cannabis: Latest Executive Changes You Should Know About – Cannabis Bioscience (OTC:CBIH), Cannabix Technologies (OTC:BLOZF) Read more
Cannabis Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More – Compass Pathways (NASDAQ:CMPS), Clearmind Medicine (NASDAQ:CMND) Read more
Biotechnology Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta’s Influence – ATAI Life Sciences (NASDAQ:ATAI), Clearmind Medicine (NASDAQ:CMND) Read more
Biotechnology Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline – Compass Pathways (NASDAQ:CMPS), ATAI Life Sciences (NASDAQ:ATAI) Read more
Biotechnology Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana’s Research And More – ATAI Life Sciences (NASDAQ:ATAI), Clearmind Medicine (NASDAQ:CMND) Read more
Biotechnology FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement – Compass Pathways (NASDAQ:CMPS), Cybin (AMEX:CYBN) Read more
Biotechnology MindMed Receives FDA ‘Breakthrough Therapy’ Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials – Compass Pathways (NASDAQ:CMPS), Mind Medicine (NASDAQ:MNMD) Read more
Biotechnology Psychedelics 2024: Veterans Blessing, Mental Health Paradigm Shift, Providers Training, Ketamine-MDMA Bonds & More – Compass Pathways (NASDAQ:CMPS), Blue Water Ventures Intl (OTC:BWVI) Read more
Biotechnology Podcast – Post-Frenzy Psychedelics Investing And Reclaiming The Right To Pursue Happiness With Zappy Zapolin: ‘2024 Is When It Goes Mainstream’ – Blue Water Ventures Intl (OTC:BWVI), Braxia Scientific (OTC:BRAXF) Read more